DS
CDLX icon

David Shaw’s Cardlytics CDLX Stock Holding History

David Shaw’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,020
Closed -$674K – 5218
2022
Q2 		$674K Buy
+3,020
New +$1.01M ﹤0.01% 3896
2021
Q2 		– Sell
-1,000
Closed -$1.1M – 4767
2021
Q1 		$1.1M Buy
1,000
+510
+104% +$673K ﹤0.01% 3041
2020
Q4 		$700K Hold
490
– – ﹤0.01% 3231
2020
Q3 		$346K Hold
490
– – ﹤0.01% 3376
2020
Q2 		$343K Buy
+490
New +$283K ﹤0.01% 3565

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

David Shaw's CDLX Position: Q1 2026 in Review

David Shaw sold out of Cardlytics (CDLX) in Q1 2026, closing a stake of 2,621 shares — an estimated $30.1K sold.

David Shaw first reported a position in CDLX in Q4 2019 and held it in 25 quarters. The position peaked at $25.6M in Q4 2019. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • David Shaw reported no remaining Cardlytics position as of Q1 2026 after selling out during the quarter.
  • David Shaw sold 2,621 Cardlytics shares in Q1 2026, an estimated $30.1K.
  • David Shaw first reported a position in Cardlytics in Q4 2019 and held it in 25 quarters.
  • David Shaw's Cardlytics position peaked at $25.6M in Q4 2019.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.